Mitral valve repair in a selected cohort of patients with degenerative mitral regurgitation resulted in a 2-year all-cause mortality of 3.5% and a 13% rate of moderate or greater MR recurrence.
Contemporary multicenter surgical cohorts demonstrate excellent early safety and 2-year durability for mitral valve repair in selected patients with degenerative mitral regurgitation, serving as a benchmark for transcatheter therapies.
Lancellotti et al. (Sun,) conducted a editorial in Degenerative mitral regurgitation (n=314). Mitral valve repair was evaluated on Moderate or greater mitral regurgitation recurrence at 2 years. Mitral valve repair in a selected cohort of patients with degenerative mitral regurgitation resulted in a 2-year all-cause mortality of 3.5% and a 13% rate of moderate or greater MR recurrence.